Micronized and Ultramicronized Palmitoylethanolamide in COVID-19 Patients
Clinical trial NCT04568876 · COMPLETED
Trial details
- NCT number
- NCT04568876
- Sponsor
- Epitech Group SpA
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-23
- Primary completion
- 2021-02-28
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.